Microscale Native Size Exclusion Chromatography High Resolution Mass Spectrometry for the Determination of the Chelator-To-Antibody Ratio of Immunoconjugates
Preprint
- 23 November 2025
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Positron emission tomography (PET) using radiolabeled antibodies (radioimmunoconjugates) is a powerful imaging technique to track the distribution of therapeutic antibodies. Accurate determination of the average number of chelators per antibody (CAR) is essential for (radio)immunoconjugate characterization. Radiometric titration, although widely used, is labor-intensive and requires approximately half a day per sample. To overcome this analytical bottleneck, we developed a microscale size exclusion chromatography – mass spectrometry (SEC-MS) analysis. Thanks to the microscale flow applied, high concentrations of volatile salts, up to 1000 mM ammonium acetate, could be used to minimize secondary interactions. The method was optimized using model radioimmunoconjugates based on intact trastuzumab, with a particular focus on the impact of buffer concentration on both chromatographic effects and CAR determination. A final buffer concentration of 600 mM ammonium acetate was selected. The method was compared to radionuclide titration for the analysis of the same immunoconjugate model, reporting similar results. Finally, we demonstrated the broad applicability of the method by testing diverse immunoconjugates (ipilimumab), including cysteine and lysine-linked chelator samples, as well as other smaller protein models, such as nanobodies. With a 20-min run time, the averageCAR, dispersity index, glycosylation profile, and impurities could all be determined. This approach offers a broadly applicable alternative for radiometric titration for the characterization of immunoconjugates.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Unveiling the chemistry of antibody conjugation for enhanced PET imaging: Current trends and future directionsBioorganic Chemistry, 2024
- Automated high-throughput buffer exchange platform enhances rapid flow analysis of antibody drug conjugates by high resolution mass spectrometryJournal of Chromatography B, 2024
- Micro-flow size-exclusion chromatography for enhanced native mass spectrometry of proteins and protein complexesAnalytica Chimica Acta, 2023
- Investigating the secondary interactions of packing materials for size-exclusion chromatography of therapeutic proteinsJournal of Chromatography A, 2022
- Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Cancer Imaging with Radiolabeled Monoclonal Antibodies2020
- Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?Journal of Chromatography A, 2019
- Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteinsJournal of Chromatography B, 2018
- Extending the limits of size exclusion chromatography: Simultaneous separation of free payloads and related species from antibody drug conjugates and their aggregatesJournal of Chromatography A, 2018
- Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ionsAnalytical Biochemistry, 1984